![]() |
市場調查報告書
商品編碼
1986772
寵物糖尿病照護市場報告:按解決方案、動物種類、分銷管道和地區分類(2026-2034 年)Pet Diabetes Care Market Report by Solution (Treatment, Glucose Monitoring Devices), Animal Type (Dogs, Cats), Distribution Channel (Veterinary Hospitals and Clinics, Retail Pharmacies, Online Stores), and Region 2026-2034 |
||||||
2025年,全球寵物糖尿病照護市場規模達23億美元。展望未來,IMARC Group預測,到2034年,該市場規模將達到40億美元,2026年至2034年的複合年成長率為6.17%。推動這一成長的關鍵因素包括寵物肥胖症的日益普遍、寵物「人性化」的興起、主要企業廣泛的研發活動以及消費者購買力的提高。
獸醫糖尿病照護是指獸醫學中專門診斷、治療和管理犬貓糖尿病的領域。它涵蓋了對患有糖尿病的寵物的全面護理和支持。糖尿病是一種慢性疾病,其特徵是身體無法正常調節血糖值。獸醫糖尿病照護包括定期血糖監測、胰島素注射、飲食管理和生活方式調整等多個面向。接受過該領域培訓的獸醫和獸醫專業人員與飼主密切合作,制定個人化的治療方案,提供疾病相關知識,並提供持續的支援。獸醫糖尿病照護的目標是透過結合醫療干預、飲食管理和生活方式改善,最佳化寵物的生命質量,預防糖尿病相關的健康併發症,並有效控制血糖。
久坐的生活方式、肥胖、遺傳傾向以及寵物因老化而導致的糖尿病盛行率上升,將在預測期內推動市場成長。此外,寵物「人性化」趨勢的興起以及飼主日益成長的為愛寵提供最佳醫療保健的願望,正在加速飼主對相關產品的接受度。飼主願意在定期獸醫檢查、糖尿病管理工具和專業營養療法方面投入更多,以確保寵物獲得適當且及時的護理。此外,獸醫學和技術的許多進步,包括寵物糖尿病治療方案的擴展(例如改良的胰島素配方、血糖值監測設備以及可實現遠端監測和諮詢的遠距遠端照護解決方案),也在促進市場成長。同時,飼主和獸醫專業人員對寵物糖尿病的認知和知識的普及也有助於市場成長。
寵物肥胖率上升
寵物肥胖症的日益普遍是推動寵物糖尿病照護解決方案需求成長的主要因素。隨著越來越多的寵物超重或肥胖,它們患糖尿病的風險也隨之增加。寵物飼主越來越意識到寵物肥胖帶來的健康風險,包括糖尿病風險的增加,因此他們正在尋求解決和預防這些問題的方案。由此,市場對體重管理計劃、特製食品和運動計劃的需求日益成長,這些計劃旨在幫助寵物保持健康體重,並降低糖尿病及相關疾病的風險。此外,人們對寵物肥胖症日益成長的關注也推動了新型寵物糖尿病護理產品和服務的發展,這些產品和服務旨在透過有效的體重管理策略幫助飼主預防和控制寵物糖尿病。
人們對寵物健康和保健的興趣日益濃厚
人們對寵物健康和福祉日益關注,這是推動市場發展的另一個主要因素。飼主在確保寵物整體健康方面投入巨資,並尋求預防性醫療保健方案以及對糖尿病等慢性疾病的全面管理。他們更積極主動監測寵物的健康狀況,定期帶寵物進行獸醫檢查,並更加關注潛在的健康問題。寵物飼主健康意識的顯著轉變,導致對寵物糖尿病專業照護的需求增加,包括定期血糖值監測、胰島素注射和飲食管理。市場正透過創新產品和服務來應對這一趨勢,例如先進的血糖監測系統、胰島素筆和糖尿病寵物食品。寵物飼主也積極尋求有關寵物糖尿病管理的資訊和資源,從而迅速提高人們對此主題的認知和了解。
獸醫學和技術的進步
獸醫學和技術的持續進步顯著改善了寵物糖尿病的管理,為市場帶來了積極的變革。這些進步包括開發出更精準、更容易使用的血糖值監測系統,使飼主能夠方便、準確地監測寵物的血糖值。此外,遠端醫療和遠端監測工具的引入,使得糖尿病管理更加便捷高效,飼主無需頻繁前往寵物醫院即可獲得獸醫的指導和支持。同時,電子健康記錄和數據分析的廣泛應用也提升了糖尿病寵物的整體管理和治療效果。這些獸醫學和技術的創新為寵物飼主提供了更好的工具和資源來管理寵物的疾病,從而改善了糖尿病寵物的整體護理和生活品質。
The global pet diabetes care market size reached USD 2.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 4.0 Billion by 2034, exhibiting a growth rate (CAGR) of 6.17% during 2026-2034. The increasing prevalence of obesity in pets, the emerging pet humanization trend, extensive research and development (R&D) activities by key players, and rising expenditure capacities of consumers are some of the major factors propelling the market.
Pet diabetes care refers to the specialized field of veterinary medicine that deals with the diagnosis, treatment, and management of diabetes in dogs and cats. It involves comprehensive care and support for pets with diabetes mellitus, a chronic condition characterized by the body's inability to properly regulate blood sugar levels. Pet diabetes care encompasses various aspects, including the regular monitoring of blood glucose levels, insulin administration, dietary management, and lifestyle modifications of pets. Veterinarians and veterinary professionals trained in this field work closely with pet owners to create individualized treatment plans, educate them about the disease, and provide ongoing support. The goal of pet diabetes care is to optimize the pet's quality of life, prevent health complications associated with diabetes, and achieve efficient glycemic control through a combination of medical intervention, dietary management, and lifestyle modifications.
The rising prevalence of diabetes in pets due to sedentary lifestyles, obesity, genetic predisposition, and an aging pet population will stimulate the growth of the market during the forecast period. Moreover, the emerging trend of pet humanization and the growing desire of pet owners to provide optimal healthcare for companion animals have accelerated the product adoption rate among pet owners. Pet owners are willing to invest more in regular veterinary visits, diabetes management tools, and specialized diets to ensure that their pets receive proper and timely care. Apart from this, numerous advancements in veterinary medicine and technology, including the expansion of the range of treatment options available for pet diabetes such as improved insulin formulations, glucose monitoring devices, and telemedicine solutions that facilitate remote monitoring and consultation is propelling the market growth. Furthermore, the heightening awareness and education about pet diabetes among owners and veterinary professionals is contributing to the market growth.
Increase in pet obesity rates
The rising prevalence of obesity among pets is a major factor driving the demand for pet diabetes care solutions. As more and more pets become overweight or obese, they are at a higher risk of developing diabetes. Pet owners are becoming increasingly aware of the health risks associated with obesity in their pets, including the higher likelihood of diabetes, and are therefore seeking solutions to address and prevent these conditions. This in turn has led to a growing demand for weight management programs, specialized diets, and exercise regimens designed to help pets maintain a healthy weight and reduce the risk of developing diabetes and associated conditions. Besides this, the increasing focus on combating pet obesity is encouraging the development of new products and services related to pet diabetes care, aimed at helping pet owners prevent and manage diabetes through effective weight management strategies.
Growing focus on pet health and wellness
The growing focus on pet health and wellness is another major driver in the market. Pet owners are heavily investing in ensuring the overall well-being of their pets and are seeking preventive healthcare solutions and comprehensive management of chronic conditions like diabetes. They have become more proactive in monitoring their pets' health, are going for regular veterinary check-ups and being more vigilant about potential health issues. This substantial shift in pet owners' mindset has strengthened the demand for specialized pet diabetes care, including regular monitoring of blood glucose levels, insulin administration, and dietary management. The market is responding to this trend by offering innovative products and services such as advanced glucose monitoring systems, insulin pens, and specialized diabetic pet food formulations. Pet owners are also actively seeking information and resources on managing diabetes in pets, leading to a surge in awareness and education on the topic.
Advancements in veterinary medicine and technology
Constant advancements in veterinary medicine and technology have significantly improved the management of diabetes in pets and are driving positive changes in the market. These advancements include the development of more accurate and user-friendly glucose monitoring systems, which enable pet owners to monitor their pets' blood sugar levels conveniently and accurately. Additionally, the integration of telemedicine and remote monitoring tools has enabled more convenient and efficient diabetes management, as pet owners can receive guidance and support from veterinary professionals without the need for frequent in-person visits. Furthermore, the increasing use of electronic health records and data analytics has improved the overall management and treatment outcomes of pets with diabetes. These innovations in veterinary medicine and technology are providing pet owners with better tools and resources for managing the disease in their pets, enhancing the overall care and quality of life for diabetic pets.
Treatment represents the most popular solution
Treatment plays a crucial role in driving the market growth as it encompasses a range of interventions and therapies aimed at managing diabetes in pets. Effective treatment options are essential to provide optimal care and improve the quality of life for pets with diabetes. Treatment fuels the market growth by creating a consistent and steady demand for various products and services, such as insulin formulations, glucose monitoring systems, specialized diabetic pet food, and veterinary consultations.
Furthermore, the easy availability of diverse treatment options allows pet owners and veterinary professionals to tailor the management approach to the individual needs of each pet, which in turn is propelling the market growth. Moreover, ongoing advancements in treatment options, including improved insulin formulations and delivery methods, advanced glucose monitoring technologies, and personalized nutrition, further contribute to the growth of the market.
Dogs dominate the market
Dogs play a significant role in propelling the market due to their high prevalence of diabetes and the growing awareness of this condition among dog owners. Dogs are more susceptible to developing diabetes compared to other pets, and as a result, there is a greater demand for specialized care and management options for diabetic dogs. The increasing prevalence of obesity in dogs, which is a major risk factor for diabetes, further contributes to the need for pet diabetes care solutions for dogs.
Furthermore, dog owners are becoming more educated about the symptoms, diagnosis, and treatment of diabetes in dogs, leading to more frequent veterinary visits and the adoption of appropriate disease management strategies. This growing awareness drives the development and availability of specific products and services tailored to diabetic dogs, including glucose monitoring devices, insulin formulations, diabetic dog food, and educational resources. The unique role of dogs in the market for pet diabetes care underscores the importance of addressing their specific needs and fueling advancements in diabetes management for this companion animal.
Veterinary hospitals and clinics hold the largest share in the market
Veterinary hospitals and clinics are the primary providers of specialized care and treatment for pets with diabetes. These healthcare facilities serve as the central hub for diagnosing, monitoring, and managing diabetes in pets. Veterinary hospitals and clinics offer crucial services such as blood glucose monitoring, insulin administration, dietary counseling, and regular check-ups to ensure effective diabetes management in pets. They play a vital role in educating pet owners about the importance of diabetes care, including the need for regular veterinary visits, adherence to treatment plans, and lifestyle modifications. Furthermore, these healthcare facilities often stock and dispense diabetes-related products such as insulin, glucose monitoring devices, and specialized diabetic pet food, contributing to the widespread availability and accessibility of these essential supplies. Veterinary hospitals and clinics are at the forefront of research and advancements in pet diabetes care, driving innovations and improving treatment options. Their expertise and guidance are crucial in improving the quality of life of pets with diabetes and fostering the growth of the market.
North America exhibits a clear dominance in the market
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest regional market for pet diabetes care.
North America held the biggest share in the market since the region has a high pet ownership rate and a strong culture of pet care, resulting in a large market for pet healthcare products and services, including diabetes care. The rising awareness and understanding of pet diabetes among pet owners in North America contributes to the high demand for specialized care and treatment options. Veterinary clinics and hospitals in the North America region are at the forefront of research, innovation, and advancements in pet diabetes management, fostering the development of new products and treatment protocols.
Additionally, North America has a well-established veterinary healthcare infrastructure with an extensive network of veterinary professionals and specialized pet care facilities, ensuring easy accessibility to pet diabetes care. The large presence of leading pharmaceutical and healthcare companies in the region further supports the growth of the market in North America through the development and distribution of diabetes management products, including insulin, glucose monitoring devices, and specialized pet food.
The market is experiencing a lower-than-anticipated demand compared to pre-pandemic levels. However, this is likely to witness a paradigm shift over the next decade with the development of advanced glucose monitoring systems specifically designed for pets. Moreover, there have been advancements in insulin formulations and delivery methods, offering improved options for insulin administration and absorption. Key players are also introducing long-acting insulin formulations that provide more stable blood glucose control and reduce the frequency of injections. Additionally, the leading manufacturers are integrating telemedicine and remote monitoring technologies, enabling pet owners to consult with veterinary professionals and receive guidance on diabetes management from the comfort of their homes. We also expect the market to witness new entrants, consolidation of product portfolios, increased research-related efforts by key players, and a rise in strategic collaborations to drive healthy competition within the domain.